Although high-dose TNF-α has been utilized as a cytotoxic agent over the past few decades, recent preclinical cancer models support the link between chronic, low-level exposure to TNF-α, and the development of pro-malignant phenotypes [5,6]. This evidence concerns the gene TNF and cancer.